Literature DB >> 7801423

In situ extracorporeal shockwave lithotripsy of distal ureteral stones: parameters for therapeutic success.

P Mattelaer1, T Schröder, N Fischer, G Jakse.   

Abstract

Between January and December 1989, 123 patients with distal ureteral stones were treated with in situ extracorporeal shockwave lithotripsy (ESWL) using a modified HM3 Dornier lithotriptor. One hundred and three patients (83.7%) were stone-free, 20 patients (16.3%) had small residual stones (< 1 mm2) that passed spontaneously. In situ ESWL treatment alone was successful in 88 of the 103 stone-free patients (85.4%). Fifty-six (54.4%) needed 1 ESWL session, 26 (25.2%) needed 2 ESWL sessions. Nineteen of the 123 patients (15.4%) needed auxiliary endourological measures. The results of ESWL treatment were correlated to pretherapeutically identified parameters such as stone size, radiopacity, outer contour, shape, inner structure, biochemical analysis of the stones and grade of dilatation of the upper urinary tract. The results prove that size (> or = 75 mm2), radiopacity and grade of dilatation have a direct correlation to the difficulty to disintegrate ureteral stones.

Entities:  

Mesh:

Year:  1994        PMID: 7801423     DOI: 10.1159/000282642

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  3 in total

1.  Evaluation of computed tomography findings for success prediction after extracorporeal shock wave lithotripsy for urinary tract stone disease.

Authors:  Serdar Celik; Ozan Bozkurt; Fatih Gulbey Kaya; Sedat Egriboyun; Omer Demir; Mustafa Secil; Ilhan Celebi
Journal:  Int Urol Nephrol       Date:  2014-10-14       Impact factor: 2.370

2.  Simple radiological indicators for staghorn calculi response to ESWL.

Authors:  M S Murshidi
Journal:  Int Urol Nephrol       Date:  2006       Impact factor: 2.370

3.  The usefulness of stone density and patient stoutness in predicting extracorporeal shock wave efficiency: Results in a North African ethnic group.

Authors:  Hamdoune Abdelaziz; Yassine Elabiad; Ilyas Aderrouj; Abdellatif Janane; Mohamed Ghadouane; Ahmed Ameur; Mohamed Abbar
Journal:  Can Urol Assoc J       Date:  2014-07       Impact factor: 1.862

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.